Cellective BioTherapy Overview

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

Cellective BioTherapy General Information

Description

Developer of a biotechnology platform designed to enhance or inhibit immune responses. The company's platform provides the ability to expand human B cells for use as autologous cellular immunotherapy for treating cancers, autoimmunity, and immunodeficiency, enabling physicians to treat patients without destroying essential cells and their protective functions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6 Davis Drive
  • Research Triangle Park
  • Durham, NC 27709
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 6 Davis Drive
  • Research Triangle Park
  • Durham, NC 27709
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellective BioTherapy Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-Jul-2023 Completed Pre-Clinical Trials
5. Early Stage VC (Series A) 26-May-2015 Completed Startup
4. Accelerator/Incubator Completed Startup
3. Early Stage VC Completed Startup
2. Merger/Acquisition Completed Startup
1. University Spin-Out 01-Jan-2015 Completed Startup
To view Cellective BioTherapy’s complete valuation and funding history, request access »

Cellective BioTherapy Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Cellective BioTherapy’s complete cap table history, request access »

Cellective BioTherapy Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eshelman Ventures Venture Capital Minority
Sofinnova Investments Venture Capital Minority
To view Cellective BioTherapy’s complete investors history, request access »

Cellective BioTherapy FAQs

  • Where is Cellective BioTherapy headquartered?

    Cellective BioTherapy is headquartered in Durham, NC.

  • What industry is Cellective BioTherapy in?

    Cellective BioTherapy’s primary industry is Drug Discovery.

  • Is Cellective BioTherapy a private or public company?

    Cellective BioTherapy is a Private company.

  • What is Cellective BioTherapy’s current revenue?

    The current revenue for Cellective BioTherapy is .

  • How much funding has Cellective BioTherapy raised over time?

    Cellective BioTherapy has raised $2.5M.

  • Who are Cellective BioTherapy’s investors?

    Eshelman Ventures and Sofinnova Investments have invested in Cellective BioTherapy.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »